0001209191-23-060006.txt : 20231229 0001209191-23-060006.hdr.sgml : 20231229 20231229163336 ACCESSION NUMBER: 0001209191-23-060006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231229 FILED AS OF DATE: 20231229 DATE AS OF CHANGE: 20231229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kobayashi Ken CENTRAL INDEX KEY: 0002003383 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40881 FILM NUMBER: 231528136 MAIL ADDRESS: STREET 1: 321 HARRISON AVENUE STREET 2: 11TH FLOOR, SUITE 1 CITY: BOSTON STATE: MA ZIP: 02118 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pyxis Oncology, Inc. CENTRAL INDEX KEY: 0001782223 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831160910 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 321 HARRISON AVENUE CITY: BOSTON STATE: MA ZIP: 02118 BUSINESS PHONE: (617) 221-9059 MAIL ADDRESS: STREET 1: 321 HARRISON AVENUE CITY: BOSTON STATE: MA ZIP: 02118 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-29 0 0001782223 Pyxis Oncology, Inc. PYXS 0002003383 Kobayashi Ken C/O PYXIS ONCOLOGY, INC. 321 HARRISON AVENUE BOSTON MA 02118 0 1 0 0 Chief Medical Officer 0 Stock Option (Right to Buy) 1.80 2023-12-29 4 A 0 443514 0.00 A 2033-12-29 Common Stock 443514 443514 D Stock Option (Right to Buy) 1.80 2023-12-29 4 A 0 110878 0.00 A 2033-12-29 Common Stock 110878 110878 D The shares subject to this option will vest over four years, with 25% vesting on November 27, 2024 and the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued employment through the applicable vesting dates. The shares subject to this option will vest upon the achievement of certain clinical milestones related to data disclosure for PYX-201. /s/ Pamela Connealy, Attorney-in-Fact for Ken Kobayashi 2023-12-29